HALL LAURIE J TRUSTEE - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 152 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.

Quarter-by-quarter ownership
HALL LAURIE J TRUSTEE ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2022$1
-100.0%
85
-34.6%
0.00%
-100.0%
Q3 2022$2,000
+100.0%
130
+44.4%
0.00%
Q2 2022$1,0000.0%900.0%0.00%
Q1 2022$1,0000.0%900.0%0.00%
Q4 2021$1,0000.0%900.0%0.00%
Q3 2021$1,000
-66.7%
90
-35.7%
0.00%
-100.0%
Q2 2021$3,0000.0%1400.0%0.00%0.0%
Q1 2021$3,0000.0%1400.0%0.00%0.0%
Q4 2020$3,000
-50.0%
1400.0%0.00%
-66.7%
Q3 2020$6,000
-50.0%
140
+40.0%
0.00%
-50.0%
Q4 2019$12,000
+140.0%
100
+25.0%
0.01%
+100.0%
Q3 2019$5,000
+25.0%
80
+60.0%
0.00%
+50.0%
Q2 2019$4,000
-33.3%
500.0%0.00%
-33.3%
Q1 2019$6,0000.0%500.0%0.00%0.0%
Q4 2018$6,000
-25.0%
50
-16.7%
0.00%
-25.0%
Q3 2018$8,000
+60.0%
600.0%0.00%
+33.3%
Q2 2018$5,000
+25.0%
600.0%0.00%
+50.0%
Q1 2018$4,0000.0%600.0%0.00%0.0%
Q4 2017$4,000600.00%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 185,781$4,611,56512.16%
Samsara BioCapital, LLC 640,688$11,878,3563.64%
ALPINE ASSOCIATES MANAGEMENT INC. 2,203,295$40,849,0892.14%
Versor Investments LP 378,480$7,017,0191.42%
Magnetar Financial LLC 2,407,209$44,629,6551.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,077,893$38,524,1360.85%
Fort Baker Capital Management LP 430,600$7,983,3240.74%
EHP Funds Inc. 84,210$1,561,2530.73%
Terrapin Asset Management, LLC 30,000$556,2000.63%
AQR Arbitrage LLC 734,970$13,626,3440.61%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders